Sun Pharmaceutical enters into merger agreement with Taro Pharmaceutical
We are advising Sun Pharma on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
Air Methods emerges from chapter 11
We advised the ad hoc group that negotiated and backstopped the restructuring
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Genetron $126 million going-private transaction
We are separately advising Genetron and the special committee of its board on the transaction
PracticeTek merger with Integrated Practice Solutions and related financing
We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
Abcam $5.7 billion acquisition by Danaher
We advised financial advisers to Abcam on the transaction
SSI Strategy acquisition of NDA Group
We advised SSI Strategy on the acquisition